Allscripts to Buy Back $350M in Stock; Shares Jump 5%
Allscripts (MDRX) announced a new share repurchase program through which the company may buy up to $350 million shares. Following the share buyback announcement, Allscripts rose almost 5% on May 26 to close at $17.48. The company provides healthcare information technology solutions that advance clinical, financial and operational results. Under the program, the company plans to buy back shares in the open market or through private negotiations, subject to market conditions. This repurchase program has no termination date. The new buyback program replaces the company’s previous $300 mill...